Skip to main content
. 2022 Aug 28;8(9):e10416. doi: 10.1016/j.heliyon.2022.e10416

Table 2.

PLAAT4 expression associated with clinicopathological characteristics (logistic regression).

Characteristics Total(N) Odds Ratio (OR) P value
T stage (T3 & T4 vs. T1 & T2) 176 1.373 (1.009–1.882) 0.044
N stage (N1 vs. N0) 173 1.292 (0.989–1.706) 0.063
M stage (M1 vs. M0) 84 0.581 (0.290–1.148) 0.104
Pathologic stage (Stage II & Stage III & Stage IV vs. Stage I) 175 1.473 (1.034–2.111) 0.031
Radiation therapy (Yes vs. No) 163 0.916 (0.698–1.206) 0.529
Primary therapy outcome (PR & CR vs. PD & SD) 139 0.802 (0.591–1.068) 0.141
Gender (Male vs. Female) 178 0.977 (0.769–1.239) 0.847
Race (White vs. Asian & Black or African American) 174 1.218 (0.822–1.776) 0.312
Age (>65 vs. ≤65) 178 0.917 (0.721–1.161) 0.473
Residual tumor (R1 & R2 vs. R0) 164 1.423 (1.082–1.911) 0.015
Histologic grade (G3 & G4 vs. G1 & G2) 176 1.411 (1.065–1.912) 0.021
Anatomic neoplasm subdivision (Other vs. Head of Pancreas) 178 0.709 (0.529–0.937) 0.017
Smoker (Yes vs. No) 144 1.182 (0.911–1.550) 0.212
Alcohol history (Yes vs. No) 166 1.118 (0.872–1.439) 0.378
History of diabetes (Yes vs. No) 146 0.992 (0.737–1.345) 0.956
History of chronic pancreatitis (Yes vs. No) 141 2.199 (1.292–3.994) 0.006